Immunohistochemical (IHC) diagnostics play an important role in the diagnosis of prostate cancer, particularly in differentiating between benign and malignant prostate diseases and in determining the type of tumor. Prostate cancer is the most common cancer in men in Germany, accounting for 26% of all cancers.
Learn moreSelecting your region and language ensures you receive the corresponding product portfolio and contact details.